MRNA Executive Compensation

* In USD (Original Currency)
Filing Date
(SEC Report)
Year Reporting Name Salary Bonus Stock Award Incentive Plan Compensation Other Compensation Total
2023-03-15 2022 Arpa Garay Chief Commercial Officer 458,462 1,500,000 2,502,713 508,932 203,303 7,676,152
2023-03-15 2020 Juan Andres President, Strategic Partnerships and Enterprise Expansion 548,712 662,400 750,000 0 36,711 4,247,823
2023-03-15 2021 Juan Andres President, Strategic Partnerships and Enterprise Expansion 590,769 0 2,500,000 756,000 256,713 6,603,482
2023-03-15 2022 Juan Andres President, Strategic Partnerships and Enterprise Expansion 684,616 0 2,398,002 567,000 26,581 6,074,365
2023-03-15 2022 Stéphane Bancel Chief Executive Officer 1,423,077 0 3,597,152 2,700,000 851,562 19,363,648
2023-03-15 2021 Stéphane Bancel Chief Executive Officer 990,385 0 3,750,000 1,500,000 665,354 18,155,739
2023-03-15 2020 Stéphane Bancel Chief Executive Officer 945,673 1,900,000 0 0 1,009,602 12,885,275
2023-03-15 2022 James Mock Chief Financial Officer 227,885 1,000,000 2,919,660 259,644 4,327 7,331,196
2023-03-15 2022 David Meline Former Chief Financial Officer 426,497 428,055 1,918,342 0 76,718 4,768,145
2023-03-15 2021 David Meline Former Chief Financial Officer 616,962 0 2,000,000 560,000 59,312 5,236,274
2023-03-15 2020 David Meline Former Chief Financial Officer 334,616 339,344 0 0 0 9,273,960
2023-03-15 2022 Stephen Hoge, M.D. President 953,846 0 3,117,492 1,440,000 17,735 8,646,652
2023-03-15 2021 Stephen Hoge, M.D. President 684,808 0 3,000,000 819,000 299,624 7,803,432
2023-03-15 2020 Stephen Hoge, M.D. President 617,366 621,000 1,000,000 0 24,930 5,263,296
2023-03-15 2022 Jorge Gomez Former Chief Financial Officer 5,385 0 0 0 431,668 437,053
2022-03-09 2021 David Meline Chief Financial Officer 616,962 0 2,000,000 560,000 59,312 5,236,274
2022-03-09 2020 David Meline Chief Financial Officer 334,616 339,344 0 0 0 9,273,960
2022-03-09 2021 Stephen Hoge, M.D. President 684,808 0 3,000,000 819,000 299,624 7,803,432
2022-03-09 2020 Stephen Hoge, M.D. President 617,366 621,000 1,000,000 0 24,930 5,263,296
2022-03-09 2019 Stephen Hoge, M.D. President 595,724 396,000 0 0 9,490 5,001,214
2022-03-09 2021 Juan Andres Chief Technical Operations & Quality Officer 590,769 0 2,500,000 756,000 256,713 6,603,482
2022-03-09 2021 Stéphane Bancel Chief Executive Officer 990,385 0 3,750,000 1,500,000 665,354 18,155,739
2022-03-09 2020 Juan Andres Chief Technical Operations & Quality Officer 548,712 662,400 750,000 0 36,711 4,247,823
2022-03-09 2019 Juan Andres Chief Technical Operations & Quality Officer 530,615 322,465 0 0 9,490 3,862,570
2022-03-09 2021 Shannon Thyme Klinger Chief Legal Officer & Corporate Secretary 381,096 250,000 6,000,000 344,000 514,051 11,489,147
2022-03-09 2021 Corinne Le Goff Former Chief Commercial Officer 570,205 300,000 4,000,000 0 1,278,243 10,148,448
2022-03-09 2020 Stéphane Bancel Chief Executive Officer 945,673 1,900,000 0 0 1,009,602 12,855,275
2022-03-09 2019 Stéphane Bancel Chief Executive Officer 921,217 1,017,500 0 0 9,490 8,948,207
2021-03-10 2019 Stephen Hoge, M.D. President 595,724 396,000 0 0 9,490 5,001,214
2021-03-10 2020 Stéphane Bancel Chief Executive Officer 945,673 1,900,000 0 0 1,009,602 12,855,275
2021-03-10 2019 Stéphane Bancel Chief Executive Officer 921,217 1,017,500 0 0 9,490 8,948,207
2021-03-10 2018 Stéphane Bancel Chief Executive Officer 863,077 1,800,000 0 0 9,639 58,608,484
2021-03-10 2020 David Meline Chief Financial Officer 334,616 339,344 0 0 0 9,273,960
2021-03-10 2020 Lorence Kim, M.D. Former Chief Financial Officer 418,211 145,000 0 0 330,775 3,393,986
2021-03-10 2019 Lorence Kim, M.D. Former Chief Financial Officer 560,401 278,685 0 0 258,479 3,597,565
2021-03-10 2018 Lorence Kim, M.D. Former Chief Financial Officer 542,769 450,450 0 0 228,386 9,038,117
2021-03-10 2020 Stephen Hoge, M.D. President 617,366 621,000 1,000,000 0 24,930 5,263,296
2021-03-10 2018 Stephen Hoge, M.D. President 570,004 629,200 0 0 9,639 4,726,274
2021-03-10 2020 Tal Zaks Chief Medical Office r 548,712 552,000 750,000 0 152,269 4,252,981
2021-03-10 2019 Tal Zaks Chief Medical Office r 530,630 293,150 0 0 8,646 4,832,426
2021-03-10 2020 Juan Andres Chief Technical Operations and Quality Officer 548,712 662,400 750,000 0 36,711 4,247,823
2021-03-10 2019 Juan Andres Chief Technical Operations and Quality Officer 530,615 322,465 0 0 9,490 3,862,570
2020-03-16 2019 Juan Andres 530,615 322,465 0 0 9,490 3,862,570
2020-03-16 2019 Lorence Kim, M.D. Chief Financial Officer 560,401 278,685 0 0 258,479 3,597,565
2020-03-16 2018 Lorence Kim, M.D. Chief Financial Officer 542,769 450,450 0 0 228,386 9,038,117
2020-03-16 2019 Stephen Hoge, M.D. President 595,724 396,000 0 0 9,490 5,001,214
2020-03-16 2018 Stephen Hoge, M.D. President 570,004 629,200 0 0 9,639 4,726,274
2020-03-16 2019 Tal Zaks 530,630 293,150 0 0 8,646 4,832,426
2020-03-16 2019 Stéphane Bancel Chief Executive Officer 921,217 1,017,500 0 0 9,490 8,948,207
2020-03-16 2018 Stéphane Bancel Chief Executive Officer 863,077 1,800,000 0 0 9,639 58,608,484
2019-05-15 2018 Lorence Kim, M.D. Chief Financial Officer 542,769 450,450 0 0 228,386 9,038,117
2019-05-15 2018 John Mendlein, Ph.D., J.D. 500,000 400,000 0 0 8,533 26,163,117
2019-05-15 2017 Stéphane Bancel Chief Executive Officer 650,769 1,500,000 0 0 10,420 6,809,189
2019-05-15 2018 Stéphane Bancel Chief Executive Officer 863,077 1,800,000 0 0 9,639 58,608,484
2019-05-15 2017 Lorence Kim, M.D. Chief Financial Officer 521,154 1,000,000 5,470,000 0 166,633 9,315,787

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.